GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (MEX:BNGO) » Definitions » Other Operating Expense

Bionano Genomics (MEX:BNGO) Other Operating Expense : MXN0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bionano Genomics Other Operating Expense?

Bionano Genomics's Other Operating Expense for the three months ended in Dec. 2024 was MXN-0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was MXN0.0 Mil.

Bionano Genomics's quarterly Other Operating Expense declined from Jun. 2024 (MXN0.0 Mil) to Sep. 2024 (MXN-0.0 Mil) but then increased from Sep. 2024 (MXN-0.0 Mil) to Dec. 2024 (MXN-0.0 Mil).

Bionano Genomics's annual Other Operating Expense increased from Dec. 2022 (MXN-0.0 Mil) to Dec. 2023 (MXN0.0 Mil) but then declined from Dec. 2023 (MXN0.0 Mil) to Dec. 2024 (MXN-0.0 Mil).


Bionano Genomics Other Operating Expense Historical Data

The historical data trend for Bionano Genomics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics Other Operating Expense Chart

Bionano Genomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only - - - - -

Bionano Genomics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bionano Genomics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bionano Genomics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Bionano Genomics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionano Genomics Business Description

Traded in Other Exchanges
Address
9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.